Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma

Several reports have documented similar efficacies and tolerable toxicities of radioimmunotherapy (RIT) consolidation and rituximab maintenance after initial R-chemotherapy of follicular lymphoma. The relative merits of these two interventions are currently under discussion. We now raise the questio...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchegger, Franz, Press, Oliver W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2011
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251040/
https://www.ncbi.nlm.nih.gov/pubmed/22214546
http://dx.doi.org/10.1186/2191-219X-1-7
Descripción
Sumario:Several reports have documented similar efficacies and tolerable toxicities of radioimmunotherapy (RIT) consolidation and rituximab maintenance after initial R-chemotherapy of follicular lymphoma. The relative merits of these two interventions are currently under discussion. We now raise the question whether both RIT consolidation and rituximab maintenance should be used together aiming to augment the results achievable with R-chemotherapy.

Ejemplares similares